Evidence map›Paper›PMID 26090471›Full record

ArticleJournal of diabetes research2015

Associations of Haplotypes Upstream of IRS1 with Insulin Resistance, Type 2 Diabetes, Dyslipidemia, Preclinical Atherosclerosis, and Skeletal Muscle LOC646736 mRNA Levels.

Selma M Soyal, Thomas Felder, Simon Auer, Hannes Oberkofler, Bernhard Iglseder, Bernhard Paulweber, Silvia Dossena, Charity Nofziger, Markus Paulmichl, Harald Esterbauer and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Association ofArchives of endocrinology and metabolism · 2024
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Selma M SoyalInstitute of Pharmacology and Toxicology, Paracelsus Medical University, 5020 Salzburg, Austria.
Thomas FelderDepartment of Laboratory Medicine, Paracelsus Medical University, 5020 Salzburg, Austria.
Simon AuerDepartment of Laboratory Medicine, Paracelsus Medical University, 5020 Salzburg, Austria.
Hannes OberkoflerDepartment of Laboratory Medicine, Paracelsus Medical University, 5020 Salzburg, Austria.
Bernhard IglsederDepartment of Geriatric Medicine, Paracelsus Medical University, 5020 Salzburg, Austria.
Bernhard PaulweberDepartment of Internal Medicine I, Paracelsus Medical University, 5020 Salzburg, Austria.
Silvia DossenaInstitute of Pharmacology and Toxicology, Paracelsus Medical University, 5020 Salzburg, Austria.
Charity NofzigerInstitute of Pharmacology and Toxicology, Paracelsus Medical University, 5020 Salzburg, Austria.
Markus PaulmichlInstitute of Pharmacology and Toxicology, Paracelsus Medical University, 5020 Salzburg, Austria.
Harald EsterbauerDepartment of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria.
Franz KremplerDepartment of Internal Medicine, Krankenhaus Hallein, 5400 Hallein, Austria.
Wolfgang PatschInstitute of Pharmacology and Toxicology, Paracelsus Medical University, 5020 Salzburg, Austria.
Paracelsus Medical University · ATBarmherzige Schwestern Krankenhaus Wien · ATMedical University of Vienna · AT

Funding

Austrian Science Fund FWF V 344
6 · The paper itself

Abstract

The genomic region ~500 kb upstream of IRS1 has been implicated in insulin resistance, type 2 diabetes, adverse lipid profile, and cardiovascular risk. To gain further insight into this chromosomal region, we typed four SNPs in a cross-sectional cohort and subjects with type 2 diabetes recruited from the same geographic region. From 16 possible haplotypes, 6 haplotypes with frequencies >0.01 were observed. We identified one haplotype that was protective against insulin resistance (determined by HOMA-IR and fasting plasma insulin levels), type 2 diabetes, an adverse lipid profile, increased C-reactive protein, and asymptomatic atherosclerotic disease (assessed by intima media thickness of the common carotid arteries). BMI and total adipose tissue mass as well as visceral and subcutaneous adipose tissue mass did not differ between the reference and protective haplotypes. In 92 subjects, we observed an association of the protective haplotype with higher skeletal muscle mRNA levels of LOC646736, which is located in the same haplotype block as the informative SNPs and is mainly expressed in skeletal muscle, but only at very low levels in liver or adipose tissues. These data suggest a role for LOC646736 in human insulin resistance and warrant further studies on the functional effects of this locus.

Indexed as

Insulin Resistance5' Untranslated RegionsAsymptomatic DiseasesAtherosclerosisAustriaCase-Control StudiesCohort StudiesCross-Sectional StudiesDiabetes Mellitus, Type 2Diabetic AngiopathiesDisease ResistanceDyslipidemiasFemaleGenetic Association StudiesHaplotypesHumans5' Untranslated RegionsInsulin Receptor Substrate ProteinsIRS1 protein, humanRNA, Messenger

Identifiers

PMID26090471
PMCPMC4451528
OpenAlexW1596953107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.